Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

The role of ghrelin signalling in second-generation antipsychotic-induced weight gain.

Zhang Q, Deng C, Huang XF.

Psychoneuroendocrinology. 2013 Nov;38(11):2423-38. doi: 10.1016/j.psyneuen.2013.07.010. Epub 2013 Aug 14. Review.

PMID:
23953928
2.

Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats.

Zhang Q, He M, Deng C, Wang H, Lian J, Huang XF.

Int J Neuropsychopharmacol. 2014 May;17(5):807-18. doi: 10.1017/S1461145713001697. Epub 2014 Jan 27.

PMID:
24468236
3.

Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways.

Lian J, De Santis M, He M, Deng C.

Pharmacol Res. 2015 May-Jun;95-96:20-6. doi: 10.1016/j.phrs.2015.03.004. Epub 2015 Mar 14.

PMID:
25782398
4.

The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain.

He M, Deng C, Huang XF.

CNS Drugs. 2013 Jun;27(6):423-34. doi: 10.1007/s40263-013-0062-1. Review.

PMID:
23640535
5.

Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.

Popovic V, Doknic M, Maric N, Pekic S, Damjanovic A, Miljic D, Popovic S, Miljic N, Djurovic M, Jasovic-Gasic M, Dieguez C, Casanueva FF.

Neuroendocrinology. 2007;85(4):249-56. Epub 2007 Jun 15.

PMID:
17570902
6.

Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.

Lian J, Huang XF, Pai N, Deng C.

Psychoneuroendocrinology. 2014 Oct;48:77-86. doi: 10.1016/j.psyneuen.2014.06.010. Epub 2014 Jun 18.

PMID:
24992721
7.

Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.

Lian J, Huang XF, Pai N, Deng C.

Pharmacol Res. 2016 Apr;106:51-63. doi: 10.1016/j.phrs.2016.02.011. Epub 2016 Feb 15. Review.

PMID:
26892184
8.

Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats.

He M, Zhang Q, Deng C, Wang H, Lian J, Huang XF.

Psychoneuroendocrinology. 2014 Apr;42:153-64. doi: 10.1016/j.psyneuen.2014.01.018. Epub 2014 Jan 30.

PMID:
24636512
9.

Trajectories of agouti-related protein and leptin levels during antipsychotic-associated weight gain in patients with schizophrenia.

Ehrlich S, Leopold K, Merle JV, Theophil I, Haag W, Lautenschlager M, Schaefer M.

J Clin Psychopharmacol. 2012 Dec;32(6):767-72. doi: 10.1097/JCP.0b013e318270e5c5.

PMID:
23131879
10.

Effects of second generation antipsychotics on leptin and ghrelin.

Esen-Danaci A, Sarandöl A, Taneli F, Yurtsever F, Ozlen N.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1434-8. doi: 10.1016/j.pnpbp.2008.03.015. Epub 2008 Apr 1.

PMID:
18579280
11.

Effect of feed restriction and supplemental dietary fat on gut peptide and hypothalamic neuropeptide messenger ribonucleic acid concentrations in growing wethers.

Relling AE, Pate JL, Reynolds CK, Loerch SC.

J Anim Sci. 2010 Feb;88(2):737-48. doi: 10.2527/jas.2009-2316. Epub 2009 Nov 6.

PMID:
19897637
12.
13.

Risperidone treatment increases CB1 receptor binding in rat brain.

Secher A, Husum H, Holst B, Egerod KL, Mellerup E.

Neuroendocrinology. 2010;91(2):155-68. doi: 10.1159/000245220. Epub 2009 Oct 3.

PMID:
19815998
14.
15.
16.

Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications.

Gentile S.

Obes Rev. 2009 Sep;10(5):527-42. doi: 10.1111/j.1467-789X.2009.00589.x. Epub 2009 May 12. Review.

PMID:
19460111
17.

Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats.

Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I.

Diabetes. 2001 Nov;50(11):2438-43.

18.

Ghrelin plasma levels during psychopharmacological treatment.

Himmerich H, Fulda S, Künzel HE, Pfennig A, Dzaja A, Cummings DE, Pollmächer T.

Neuropsychobiology. 2005;52(1):11-6. Epub 2005 Jun 3.

PMID:
15942258
19.

Naturalistic impact of second-generation antipsychotics on weight gain.

Brixner DI, Said Q, Corey-Lisle PK, Tuomari AV, L'italien GJ, Stockdale W, Oderda GM.

Ann Pharmacother. 2006 Apr;40(4):626-32. Epub 2006 Mar 28.

PMID:
16569802
20.

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.

Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ.

Mol Psychiatry. 2012 Mar;17(3):242-66. doi: 10.1038/mp.2011.109. Epub 2011 Sep 6. Review.

PMID:
21894153

Supplemental Content

Support Center